161
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Role of ADAMTS5 in Unexplained Fetal Growth Restriction (FGR)

, , , , , , & show all
Pages 220-230 | Received 30 Jan 2016, Accepted 23 Mar 2016, Published online: 09 May 2016

References

  • Suneet PC, Lata MG, Nancy WH, Vincenzo B. Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines. Am J Obstet Gynecol. 2009;200(4):409.e1–6.
  • Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol. 1982;59(5):624–32.
  • Minior VK, Divon MY. Fetal growth restriction at term: myth or reality?. Obstet Gynecol. 1998;92(1):57–60.
  • Mandruzzato G, Antsaklis A, Botet F, Chervenak FA, Figueras F, Grunebaum A, Puerto B, Skupski D, Stanojevic M. Intrauterine restriction (IUGR). J Perinat Med 2008;36:277–281.
  • Dessì A, Marincola FC, Fanos V. Metabolomics and the great obstetrical syndromes-GDM, PET, and IUGR. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):156–64. doi:10.1016/j.bpobgyn.2014.04.023. Epub 2014 Aug 21.
  • Jarmuzek P, Wielgos M, Bomba-Opon D. Placental pathologic changes in gestational diabetes mellitus. Neuro Endocrinol Lett. 2015;36(2):101–5.
  • William W., Hay Jr. Care of the infant of the diabetic mother. Curr Diab Rep 2012;12:4–15. DOI: 10.1007/s11892-011-0243-6.
  • Ghidini A. Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet Gynecol Surv. 1996;51(6):376–82.
  • Almasry SM1, Eldomiaty MA, Elfayomy AK, Habib FA, Safwat MD. Structural analysis of human placental stem and terminal villi from normal and idiopathic growth restricted pregnancies. J Mol Histol. 2012;43(3):263–71. doi: 10.1007/s10735-012-9405-3.
  • Molnár A, Surányi A, Nyári T, Németh G, Pál A. Examination of placental three-dimensional power Doppler indices and perinatal outcome in pregnancies complicated by intrauterine growth restriction. Int J Gynaecol Obstet. 2015;129(1):5–8. doi: 10.1016/j.ijgo.2014.10.035. Epub 2015 Jan 7.
  • Bleker OP, Buimer M, van der Post JA, van der Veen F. Ted (G.J.) Kloosterman: on intrauterine growth. The significance of prenatal care. Studies on birth weight, placental weight and placental index. Placenta. 2006;27(11–12):1052–4. Epub 2006 Mar 3.
  • Ferrazzi E, Barbera A, Bulfamante G, Moneghini L, Pavesi A. Ischemic haemorrhagic placental damage and vascular lesions is associated with abnormal uteroplacental Doppler waveform in growth retarded fetuses. J Perinat Med. 1994;22 (Suppl 1):73–8.
  • Heinonen S, Taipale P, Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta. 2001;22(5):399–404.
  • Baschat AA. Fetal responses to placental insufficiency: an update. BJOG. 2004;111(10):1031–41.
  • Baschat AA. Fetal growth restriction—from observation to intervention. J Perinat Med. 2010;38(3):239–46.
  • Aherne W, Dunnill MS. Quantitative aspects of placental structure. J Pathol Bacteriol. 1966;91(1):123–39.
  • Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haematol. 2003;16(2):183–95.
  • Aplin JD. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci. 1991;99 (Pt 4):681–92.
  • Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187(5):1416–23.
  • Chui A, Zainuddin N, Rajaraman G, Murthi P, Brennecke SP, Ignjatovic V, et al. Placental syndecan expression is altered in human idiopathic fetal growth restriction. Am J Pathol. 2012;180(2):693–702.
  • Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 2001;11(11):S37–43.
  • Gonzalo P, Guadamillas MC, Hernández-Riquer MV, Pollán A, Grande-García A, Bartolomé RA, et al. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev Cell. 2010;18(1):77–89.
  • Lindenmair A, Nürnberger S, Stadler G, Meinl A, Hackl C, Eibl J, et al. Intact human amniotic membrane differentiated towards the chondrogenic lineage. Cell Tissue Bank. 2014;15(2):213–25.
  • Makihira S, Yan W, Murakami H, Furukawa M, Kawai T, Nikawa H, et al. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage. Endocrinology. 2003;144(6):2480–8.
  • Lee SY, Lee HS, Gil M, Kim CJ, Lee YH, Kim KR, Park CS. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) −1, −4, −5, and −14 in human placenta and gestational trophoblastic diseases. Arch Pathol Lab Med. 2014;138(5):643–50.
  • Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem. 1999;274(33):23443–50.
  • Sharghi-Namini S, Fan H, Sulochana KN, Potturi P, Xiang W, Chong YS, et al. The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor. Biochem Biophys Res Commun. 2008;371(2):215–9.
  • Red Horse K, Zhou Y, Genbacey O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114(6):744–754.
  • Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:1254–60.
  • Kingdom J, Huppertz B, Seaward G, et al. Development of the placental villous tree and its consequence for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35–43.
  • Salafia CM, Vogel CA, Vintzileos AM, et al. Placental pathologic findings in preterm birth. Am J Obstet Gynecol 1991;165:934–8.
  • Gardosi J, Mul T, Mongelli M, Fagan D. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol. 1998;105(5):524–30.
  • Beckmann CR, Ling FW, Barzansky BM, Herbert WN, Laube DW, Smith RP. Obstetrics and gynecology. 6th ed. Baltimore: Lippincott Williams & Wilkins; 2010. (Level III).
  • Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology. 1984;150(2):535–40.
  • Robert R, Robert KC. Creasy and Resnik's Maternal-Fetal Medicine. 7th ed. Philadelphia: Elsevier; 2014. p.743–755.
  • Baschat AA. Fetal responses to placental insufficiency: an update. Br J Obstet Gynaecol. 2004;11:1031–41.
  • Barker DJP, Robinson RJ, editors. Fetal and infant origins of adult disease, British Medical Journal. BMJ. 1991;302(6768):113.
  • Salafia CM, Pezzullo JC, Minior VK, Divon MY. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol. 1997;90:830–836.
  • Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L, Gratacós E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195(1):201–7.
  • Regnault TR, Galan HL, Parker TA, Anthony RV. Placental development in normal and compromised pregnancies—a review. Placenta. 2002;23:S119–29.
  • Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 2005;434(7033):648–52.
  • McCulloch DR, Nelson CM, Dixon LJ, Silver DL, Wylie JD, Lindner V, et al. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell. 2009;17(5):687–98.
  • Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem. 1999;274(33):23443–50.
  • Kumar S, Sharghi-Namini S, Rao N, Ge R. ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity. Am J Pathol. 2012;181(3):1056–68.
  • Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, Yogev Y. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.